Closing of Fundraising, Admission, and VCP Awards
TORONTO, ONTARIO, Feb. 23, 2024 (GLOBE NEWSWIRE) — THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT […]
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of COPD with Type 2 Inflammation
Priority Review granted based on positive results from two Phase 3 trials; if approved, Dupixent would be the only biologic […]
Sunrun Inc. Announces Pricing of Offering of $475 Million of Convertible Senior Notes
SAN FRANCISCO, Feb. 23, 2024 (GLOBE NEWSWIRE) — Sunrun Inc. (Nasdaq: RUN) (“Sunrun”) today announced the pricing of $475 million aggregate principal […]
